For years, the Purdue bankruptcy has been working its way through the federal court system. Earlier this year, the United States Court of Appeals for the Second Circuit affirmed the Bankruptcy Court’s order which would pave the way for qualified individuals to file claims and eventually receive money from the […]
Supreme Court
4 posts
The Supreme Court has agreed to hear arguments this December concerning Purdue Pharma’s bankruptcy claims. Until then, the high court has blocked a $6 Billion settlement fund for cases related to opioid abuse. Purdue is “confident in the legality of [our] nearly universally supported Plan of Reorganization, and optimistic the […]
In the 15th and final chapter of its series on Johnson & Johnson’s Risperdal (risperidone), the Huffington Post (10/2) “Highline” recounts how the jury in the Pledger case handed down its verdict Feb. 24, 2015, finding J&J was negligent by failing to provide an adequate warning about the risk of […]
By Buck Daniel March 20, 2013 – Two years ago, the Supreme Court severely limited the conditions under which consumers could sue generic drug manufacturers. The Pliva v. Mensing decision stated that generic manufacturers do not have control over a drug’s warning label content due to FDA regulations; and therefore, […]